Miaomiao C. Bi
Changchun, 130033, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Retraction Notice to: lncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2.
Journal: Molecular therapy. Nucleic acids
Published: September 20, 2023
RETRACTED ARTICLE: Down-regulation of lncRNA FEZF1-AS1 mediates regulatory T cell differentiation and further blocks immune escape in colon cancer.
Journal: Expert review of molecular diagnostics
Published: December 08, 2021
Comparative Efficacy and Safety of PARP Inhibitors as Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis.
Journal: Frontiers in oncology
Published: June 18, 2020
lncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2.
Journal: Molecular therapy. Nucleic acids
Published: June 16, 2020
microR-4449 Promotes Colorectal Cancer Cell Proliferation via Regulation of SOCS3 and Activation of STAT3 Signaling.
Journal: Cancer management and research
Published: June 04, 2020
LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis.
Journal: Bioscience reports
Published: April 02, 2020
Radiation therapy enhanced therapeutic efficacy of anti-PD1 against gastric cancer.
Journal: Journal of radiation research
Published: March 04, 2020
LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer.
Journal: Aging
Published: November 13, 2019
The Long Non-coding RNA HOTTIP Is Highly Expressed in Colorectal Cancer and Enhances Cell Proliferation and Invasion.
Journal: Molecular therapy. Nucleic acids
Published: November 11, 2019
Last Updated: 09/26/2026